Strug­gling Unum ex­ecs are ready to con­sid­er a sale, merg­er or any deal that comes its way

Unum $UM­RX is work­ing its way through a sur­vival plan of sorts.

Af­ter get­ting hit with a trio of FDA holds in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.